MeSH D012004 - rectal neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Fluorouracil | Adrucil | 1991-10-18 | |||
| Fluorouracil | Fluorouracil | 2000-01-27 | ||||
| Irinotecan | Irinotecan | 2008-02-27 | ||||
| Novast Laboratories | Fluorouracil | Fluorouracil | 2019-12-12 | |||
| Irinotecan | Irinotecan | 2017-05-26 | ||||
| Taro Pharmaceutical | Fluorouracil | Fluorouracil | 2003-11-05 | |||
| Rising Pharmaceuticals | Fluorouracil | Fluorouracil | 2015-04-20 | |||
| Sandoz | Fluorouracil | Fluorouracil | 2011-05-02 | |||
| Irinotecan | Irinotecan | 2008-02-27 | ||||
| Bausch Health Companies | Fluorouracil | Carac | 2000-10-27 | |||
| Fluorouracil | Efudex | 1982-01-01 | ||||
| Chartwell Pharmaceuticals | Fluorouracil | Fluoroplex | 1982-01-01 | |||
| Irinotecan | Irinotecan | 2010-04-15 | ||||
| Accord Healthcare | Fluorouracil | Fluorouracil | 2007-04-26 | |||
| Irinotecan | Irinotecan | 2008-11-21 | ||||
| Pharmacia & Upjohn | Fluorouracil | Adrucil | 1991-06-28 | |||
| Eugia Pharma Specialties | Fluorouracil | Fluorouracil | 2012-07-17 | |||
| Irinotecan | Irinotecan | 2020-11-02 |
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
73%73/100
Phase 2
12%16/132
Phase 3
19%8/42
Approved: 2Overall Success rate: 2%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use